Detalles de la búsqueda
1.
Does the Structure Matter? An External Validation and Health Economic Results Comparison of Event Simulation Approaches in Severe Obesity.
Pharmacoeconomics
; 40(9): 901-915, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35771486
2.
Replication of Published Health Economic Obesity Models: Assessment of Facilitators, Hurdles and Reproduction Success.
Pharmacoeconomics
; 39(4): 433-446, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33751452
3.
Cost-utility analysis of eprosartan compared to enalapril in primary prevention and nitrendipine in secondary prevention in Europe--the HEALTH model.
Value Health
; 12(6): 857-71, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19508663
4.
Incidence of acquired thrombotic thrombocytopenic purpura in Germany: a hospital level study.
Orphanet J Rare Dis
; 14(1): 260, 2019 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31730475
5.
Evaluation of a possible predictor for Federal Joint Committee decisions on early benefit assessments according to the German act on the reform of the market for medicinal products.
Health Policy
; 117(3): 334-44, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25059744
6.
Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy.
Clinicoecon Outcomes Res
; 3: 19-27, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21935329
Resultados
1 -
6
de 6
1
Próxima >
>>